BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 1, 2021
View Archived Issues
Study unveils a mechanistic link between LRRK2, AP2 and endocytosis in the pathogenesis of PD
Read More
Inhibition of PIP4K can be used to control regulatory T-cell activity
Read More
Novel oxidative-phosphorylation inhibitors with promising antitumor activity in vivo
Read More
Discovery of CPL-302415 as promising preclinical candidate for SLE
Read More
Loss of fbn2b tied to cardiovascular manifestations overlapping with Marfan syndrome
Read More
Eternity Bioscience patents new ADAMTS inhibitors
Read More
Fileclo Sp zoo discloses new compounds for cancer
Read More
Arbutus Biopharma identifies PD-L1 antagonists
Read More
Japanese researchers synthesize new PROTACs for cancer
Read More
Rockefeller University presents new LATS1 inhibitors
Read More
Biallelic THUMPD1 variants linked to syndromic intellectual developmental disorder
Read More
Merck & Co. structure-based design efforts lead to new nucleoside PRMT5 inhibitors
Read More
ErSO induces regression of human breast tumors in vivo
Read More
Researchers identify genetic associations with behaviors related to self-regulation and addiction
Read More
Jacobio invests in Hebecell to advance iPSC-NK cell therapy
Read More
AcureX awarded funding to support development of drug candidates for Parkinson's disease
Read More
Mindset Pharma reports preclinical data on next-generation novel 5-MeO-DMT psychedelic analogues
Read More
COL13A1 and KCNMA1 are downregulated in patients with Pompe disease
Read More
Janssen optimizes new series of PDE2A inhibitors
Read More
SPOP gene behind prostate cancer risk
Read More
All is loss for P53 mutations, study argues
Read More